Adoptive cellular immunotherapy for cancer
10.3760/cma.j.issn.1673-422X.2013.02.007
- VernacularTitle:肿瘤的过继性细胞免疫疗法
- Author:
Yiman SHANG
;
Zibing WANG
;
Yijie MA
;
Yong ZHANG
;
Quanli GAO
- Publication Type:Journal Article
- Keywords:
Neoplasms;
Immunotherapy;
Killer cells
- From:
Journal of International Oncology
2013;(2):103-106
- CountryChina
- Language:Chinese
-
Abstract:
Adoptive cellular immunotherapy (ACI) achieves the elimination and control of tumor by mobilizing the body's immune function.It also has targeted efficacy and mild untoward effects.Cytokineinduced killer cells and tumor-infiltrating lymphocytes have been widely used in clinic and have obtained preliminary efficacy.With the development and clinical application of the specific gene transfer of T cell,it will further increase the efficacy of immunotherapy.At present,improving cell culture technology and cell function and using with other treatment are the key links to improve the efficacy of ACI.
